FFAR out new targets for diabetes

Cell Metabolism
Kacey J Prentice, Michael B Wheeler

Abstract

Dyslipidemia has long been associated with β cell dysfunction in the development of diabetes. Tang et al. (2015) have now revealed that β cell short-chain fatty acid receptors FFA2 and FFA3 are activated in an autocrine fashion and reduce insulin secretion in type 2 diabetes models.

References


❮ Previous
Next ❯

Citations

Oct 27, 2020·Mini Reviews in Medicinal Chemistry·Lata RaniSukhbir Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Current Diabetes Reports
H N Ginsberg, C Tuck
Nihon rinsho. Japanese journal of clinical medicine
Toshio Murase
Recenti progressi in medicina
G Fatati
© 2022 Meta ULC. All rights reserved